80 results
Page 2 of 4
8-K
EX-99.1
bt8jy9 gn823e
8 Aug 22
VBI Vaccines Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:01am
8-K
EX-99.1
vkatgi
12 Jul 22
VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer
8:00am
8-K
EX-99.1
621sd
9 May 22
VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.1
jl1irys9usnqqyieb
5 Apr 22
VBI Vaccines Announces New Data and Progress of VBI-2900, VBI’s eVLP Coronavirus Program
8:00am
8-K
EX-99.1
4lpi2l1swd47puwgq
5 Jan 22
Regulation FD Disclosure
8:00am
8-K
EX-99.1
gc6z6jf3a 6n1
29 Sep 21
Regulation FD Disclosure
8:30am
424B5
py5r 2c9g
3 Sep 21
Prospectus supplement for primary offering
8:01am
8-K
EX-99.1
hmnhapcw
29 Jun 21
VBI Vaccines Announces Initial Positive Phase 1 Data for its eVLP Vaccine Candidate Against COVID-19
7:35am
8-K
EX-99.1
szz r8gxo
23 Jun 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
o0nicr9qc4h
1 Jun 21
VBI Vaccines to Participate in Upcoming Investor Conferences
8:30am
8-K
idimaephj04agen4e5p
1 Jun 21
VBI Vaccines to Participate in Upcoming Investor Conferences
8:30am
8-K
EX-99.1
fqpi3nawsx0 oou41
12 May 21
Regulation FD Disclosure
8:00am